BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25445503)

  • 1. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
    Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
    Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.
    Han L; Jiang B; Wu H; Zhang S; Lu X
    Int J Clin Exp Pathol; 2014; 7(10):6734-42. PubMed ID: 25400753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significantly upregulated TACSTD2 and Cyclin D1 correlate with poor prognosis of invasive ductal breast cancer.
    Lin H; Huang JF; Qiu JR; Zhang HL; Tang XJ; Li H; Wang CJ; Wang ZC; Feng ZQ; Zhu J
    Exp Mol Pathol; 2013 Feb; 94(1):73-8. PubMed ID: 23031786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podoplanin expression by cancer-associated fibroblasts predicts poor outcome in invasive ductal breast carcinoma.
    Pula B; Jethon A; Piotrowska A; Gomulkiewicz A; Owczarek T; Calik J; Wojnar A; Witkiewicz W; Rys J; Ugorski M; Dziegiel P; Podhorska-Okolow M
    Histopathology; 2011 Dec; 59(6):1249-60. PubMed ID: 22175904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of melanoma-associated antigen A9 in renal cell carcinoma.
    Hatiboglu G; Pritsch M; Macher-Goeppinger S; Zöller M; Huber J; Haferkamp A; Pahernik S; Wagener N; Hohenfellner M
    Scand J Urol; 2013 Aug; 47(4):311-22. PubMed ID: 23140095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma.
    Gu X; Fu M; Ge Z; Zhan F; Ding Y; Ni H; Zhang W; Zhu Y; Tang X; Xiong L; Li J; Qiu L; Mao Y; Zhu J
    Sci Rep; 2014 Oct; 4():6625. PubMed ID: 25315972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated IL-19 in breast cancer promotes tumor progression and affects clinical outcome.
    Hsing CH; Cheng HC; Hsu YH; Chan CH; Yeh CH; Li CF; Chang MS
    Clin Cancer Res; 2012 Feb; 18(3):713-25. PubMed ID: 22186257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis.
    Yang F; Zhou X; Miao X; Zhang T; Hang X; Tie R; Liu N; Tian F; Wang F; Yuan J
    Breast Cancer Res Treat; 2014 May; 145(1):23-32. PubMed ID: 24687377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancer.
    Ren J; Chen QC; Jin F; Wu HZ; He M; Zhao L; Yu ZJ; Yao WF; Mi XY; Wang EH; Wei MJ
    Int J Clin Exp Pathol; 2014; 7(9):5595-608. PubMed ID: 25337201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
    Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
    Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High expression levels of MAGE-A9 are correlated with unfavorable survival in lung adenocarcinoma.
    Zhai X; Xu L; Zhang S; Zhu H; Mao G; Huang J
    Oncotarget; 2016 Jan; 7(4):4871-81. PubMed ID: 26717042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of MAGE-A9 expression in patients with colorectal cancer.
    Zhan W; Zhang Z; Zhang Y; Ma J; Wu T; Gu Y; Li Y; Yang J
    Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):239-45. PubMed ID: 26516058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of MAGE-A9 is associated with unfavorable survival in esophageal squamous cell carcinoma.
    Qi Y; Cao KX; Xing FC; Zhang CY; Huang Q; Wu K; Wen FB; Zhao S; Li X
    Oncol Lett; 2017 Sep; 14(3):3415-3420. PubMed ID: 28927095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of MAGE-A9 Is Predictive of Poor Prognosis in Epithelial Ovarian Cancer.
    Xu Y; Wang C; Zhang Y; Jia L; Huang J
    Sci Rep; 2015 Jul; 5():12104. PubMed ID: 26175056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.
    Bernardi MA; Logullo AF; Pasini FS; Nonogaki S; Blumke C; Soares FA; Brentani MM
    Oncol Rep; 2012 Jan; 27(1):28-38. PubMed ID: 21956537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Brahma-related Gene 1 Expression Predicts Distant Metastasis and Shorter Survival in Patients with Invasive Ductal Carcinoma of the Breast.
    Do SI; Yoon G; Kim HS; Kim K; Lee H; Do IG; Kim DH; Chae SW; Sohn JH
    Anticancer Res; 2016 Sep; 36(9):4873-82. PubMed ID: 27630343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
    Di Saverio S; Gutierrez J; Avisar E
    Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.